To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat <font color="blue">patients_6</font> <font color="blue">with_6</font> <font color="blue">primary_7</font> <font color="blue">Raynaud_7</font> <font color="blue">'s_7</font> <font color="blue">phenomenon_7</font> <font color="blue">in_7</font> <font color="blue">South_7</font> <font color="blue">Korea_7</font> <font color="blue">;_7</font> <font color="blue">Korean_4</font> <font color="blue">Raynaud_4</font> <font color="blue">study_3</font> <font color="blue">(_3</font> <font color="blue">KOARA_3</font> <font color="blue">study_3</font> <font color="blue">)_3</font> <font color="blue">._3</font> <font color="blue">
<br>
<br>_1</font> This study examined the efficacy and safety of nifedipine sustained release ( nifedipine SR ) compared with Ginkgo biloba extract as treatment for <font color="blue">primary_1</font> <font color="blue">Raynaud_1</font> <font color="blue">'s_1</font> <font color="blue">phenomenon_1</font> <font color="blue">(_1</font> <font color="blue">RP_1</font> <font color="blue">)_1</font> in Korea . <font color="blue">Primary_1</font> <font color="blue">RP_1</font> <font color="blue">were_1</font> <font color="blue">screened_1</font> <font color="blue">and_1</font> <font color="blue">assigned_1</font> <font color="blue">to_1</font> <font color="blue">either_1</font> <font color="blue">the_1</font> <font color="blue">nifedipine_2</font> <font color="blue">SR_2</font> <font color="blue">group_2</font> <font color="blue">(_2</font> <font color="blue">Group_2</font> <font color="blue">N_2</font> <font color="blue">)_2</font> <font color="blue">or_2</font> <font color="blue">the_2</font> <font color="blue">Ginkgo_2</font> <font color="blue">biloba_2</font> <font color="blue">extract_2</font> <font color="blue">group_2</font> <font color="blue">(_2</font> <font color="blue">Group_2</font> <font color="blue">G_2</font> <font color="blue">)_2</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">ratio_1</font> <font color="blue">of_1</font> <font color="blue">2:1_1</font> <font color="blue">._1</font> After a run - in period of 2 weeks , patients received treatment for 8 weeks . We observed the percent improvement of the RP attack rate between before and after the 8-week treatment . <font color="blue">Ninety_6</font> <font color="blue">-_6</font> <font color="blue">three_6</font> <font color="blue">subjects_6</font> <font color="blue">were_3</font> <font color="blue">randomly_3</font> <font color="blue">assigned_3</font> <font color="blue">._3</font> The percent improvement in <font color="blue">Group_1</font> <font color="blue">N_1</font> was 50.1% at 8 weeks after treatment , while it was 31.0% in <font color="blue">Group_1</font> <font color="blue">G_1</font> ( p = 0.03 ) . No serious adverse events occurred , and almost adverse events were mild and improved without specific treatment . nifedipine SR was more effective than Ginkgo biloba extract for treatment of primary RP in <font color="blue">Korean_2</font> <font color="blue">patients_2</font> <font color="blue">._2</font> Both drugs were tolerable with <font color="blue">primary_1</font> <font color="blue">RP_2</font> <font color="blue">patients_2</font> <font color="blue">._2</font>